Literature DB >> 24115474

The vasculature in diabetic nephropathy: all tied up?

Manish R Maski1, Samir M Parikh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24115474      PMCID： PMC3871785          DOI： 10.1681/ASN.2013090966

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  21 in total

1.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

Authors:  Hui John Zhao; Suwan Wang; Huifang Cheng; Ming-zhi Zhang; Takamune Takahashi; Agnes B Fogo; Matthew D Breyer; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

2.  Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

Authors:  Takahiko Nakagawa; Waichi Sato; Olena Glushakova; Marcelo Heinig; Tracy Clarke; Martha Campbell-Thompson; Yukio Yuzawa; Mark A Atkinson; Richard J Johnson; Byron Croker
Journal:  J Am Soc Nephrol       Date:  2007-01-03       Impact factor: 10.121

3.  Angiopoietin-1 protects the adult vasculature against plasma leakage.

Authors:  G Thurston; J S Rudge; E Ioffe; H Zhou; L Ross; S D Croll; N Glazer; J Holash; D M McDonald; G D Yancopoulos
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

Authors:  G Thurston; C Suri; K Smith; J McClain; T N Sato; G D Yancopoulos; D M McDonald
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

Review 5.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 6.  The regulation and pharmacology of endothelial nitric oxide synthase.

Authors:  David M Dudzinski; Junsuke Igarashi; Daniel Greif; Thomas Michel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

7.  Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.

Authors:  Sik Lee; Won Kim; Sang-Ok Moon; Mi Jeong Sung; Duk Hoon Kim; Kyung Pyo Kang; Kyu Yoon Jang; Sang Yong Lee; Byung Hyun Park; Gou Young Koh; Sung Kwang Park
Journal:  Nephrol Dial Transplant       Date:  2006-11-03       Impact factor: 5.992

8.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

9.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

10.  Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

Authors:  B Hohenstein; B Hausknecht; K Boehmer; R Riess; R A Brekken; C P M Hugo
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.